Thank you very much for your email. We are far more bullish on our prospects with PV-10 and PH-10 than ever before, which of course is clearly not reflected in PVCT stock price. And we know from our interactions with FDA and Big Pharma that we are being taken very seriously. Personally, I believe our time for durable, widespread and mainstream recognition is very close.
Clearly, starting PV-10 phase 3 for melanoma, moving forward with PV-10 for liver and combo, and even breast and other cancers, and PH-10 mechanism work we mentioned is coming next month along with ongoing Moffitt MOA PV-10 work, are all tremendous signs of progress this year and into early next.
I do agree the Shareholder Base has been very patient and “long-suffering” and I for one believe the stock should be much much higher even now.
I will take your email to heart and discuss at length with our Investor Relations firm tomorrow am to see if we can help out more now ahead of news, although we do expect news even still this month.
Thanks much again for your email and confidence in us. I strongly believe we will all be richly rewarded for our patience.
Best regards, Pete
Dr.Ross got to really like his comments regarding the past mouse study... pv-10 and pd1.... I think he said VERY VERY.....hmmmmm
Dr. Ross was practically chomping at the bit when the other Doc was talking about T-Vec....It appeared that he thinks PV-10 is the bomb. Just saying..... now do I listen to NTTG or go with Ross and Webber?
Seems like the Chinese FDA is giving the Holy Grail opportunity to PVCT and letting them inject HCC tumors prior to even attempting surgery vs Chinese patients who just get plain old surgery. hmmmm
You dumb ox PV-10 is for recurrent stage 3 Melanoma that can't be ripped out. PV-10 will be used to eliminate tumors and build the immune system. The goal is PFS which they already have data on 100 plus folks that have used it for this purpose, If the poor person can't have it ripped out and it keeps coming back what should they use?
You forgot to then subtract how much it cost having a terminal liver patient sitting around for weeks waiting to die in the hospital.
T-Vec not effective for distant disease the first DR.... Then Webber says other agents..... regression in distant disease.... T-Vec is so yesterday... LOL